Finding the best prices at pharmacies near you...
  1. Conditions
  2. Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a motor neuron disease characterized by progressive degeneration of the nerve cells that enable communication between the nervous system and body's muscles. It can eventually lead to respiratory failure as patients lose the ability to control the muscles of the chest and diaphragm. 

Symptoms of ALS include loss of strength in the muscles, difficulty swallowing and breathing, weight loss, and paralysis. A number of different forms of treatment are available to slow the progression of the disease and to treat the symptoms. 

Commonly prescribed medication for ALS include special ALS drugs and medicines prescribed to treat particular symptoms.

Drugs Used To Treat Amyotrophic Lateral Sclerosis (ALS):

Photo of the drug Rilutek. Rilutek
ALS Drugs
Commonly used to treat Amyotrophic Lateral Sclerosis (ALS).
No drug image available Radicava
ALS Drugs
Commonly used to treat Amyotrophic Lateral Sclerosis (ALS).
Photo of the drug Riluzole. Riluzole
ALS Drugs
Commonly used to treat Amyotrophic Lateral Sclerosis (ALS).


Click for More Drug Results...

Drugs related to Amyotrophic Lateral Sclerosis (ALS):

Photo of the drug Rilutek. Rilutek
ALS Drugs
Commonly used to treat Amyotrophic Lateral Sclerosis (ALS).
No drug image available Radicava
ALS Drugs
Commonly used to treat Amyotrophic Lateral Sclerosis (ALS).
Photo of the drug Riluzole. Riluzole
ALS Drugs
Commonly used to treat Amyotrophic Lateral Sclerosis (ALS).
No drug image available neurontin
Anticonvulsants, Miscellaneous
Commonly used to treat partial seizures.

Blog Posts Related to Amyotrophic Lateral Sclerosis (ALS):

Over the course of 2017, the number of approvals granted by the US Food and Drug Administration (FDA) reached a 21-year high. More than 1,000 generic drugs were approved by the agency, according to FDA Commissioner Scott Gottlieb, MD, while first-time generic drug approvals numbered 74. Novel drug...

Read More... Jan 08, 2018

A new treatment option for patients with amyotrophic lateral sclerosis (ALS) is now available in US pharmacies for the first time in 22 years. Radicava (edavarone), developed and manufactured by Mitsubishi Tanabe Pharma America, was approved by the US Food and Drug Administration (FDA) in May 2017....

Read More... Aug 21, 2017

The US Food & Drug Administration (FDA) has approved the first new treatment for patients with amyotrophic lateral sclerosis (ALS) in 22 years. FDA approval for Radicava (edaravone) was granted following a six-month trial in Japan in which patients given the drug exhibited a slower rate of...

Read More... May 10, 2017




Share ModRN Health and Earn Rewards!

Login or Register to Share!


Sign In
Sign up for ModRN Health


For every friend or family member you refer you will earn 100 Reward Points on their first prescription purchase! Plus you earn Reward Points on every prescription purchase they make with their ModRN Health card.

You may share without logging in or registering, but please note you will not receive any reward points.